• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者血清脂肪因子与肝细胞损伤的相关性

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease.

作者信息

Jamali Raika, Hatami Neda, Kosari Farid

机构信息

Research Development Center, Digestive Disease Research Institute, Sina Hospital, Tehran University of Medical Sciences, Tehran, IR Iran.

Sina Hospital, Tehran University of Medical Sciences, Tehran, IR Iran.

出版信息

Hepat Mon. 2016 Apr 20;16(5):e37412. doi: 10.5812/hepatmon.37412. eCollection 2016 May.

DOI:10.5812/hepatmon.37412
PMID:27313636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4906707/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic hepatitis, which can lead to cirrhosis and hepatocellular carcinoma.

OBJECTIVES

The aim of the study was to evaluate the correlation between serum adipocytokines and the histologic findings of the liver in patients with non-alcoholic fatty liver disease (NAFLD).

PATIENTS AND METHODS

This case-control study was performed on those with persistent elevated liver enzymes and with evidence of fatty liver in ultrasonography. After exclusion of patients with other etiologies causing abnormal liver function tests, the resulting patients underwent liver biopsies. NAFLD was diagnosed based on liver histology according to the Brunt scoring system.

RESULTS

Waist circumferences and levels of blood glucose (after fasting), insulin, triglycerides, alanine aminotransferases (ALT), and aspartate aminotransferases (AST) were higher in patients with NAFLD than in those in the control group. ALT, AST, and gamma glutamine transferase (GGT) levels were lower in patients with liver steatosis of a grade of less than 33% than those with higher degrees of steatosis. Serum low-density lipoprotein (LDL), cholesterol, and hepcidin levels were significantly higher in those with lobular inflammation of grade 0 - 1 than in those with inflammation of grade 2 - 3 (Brunt score). Meanwhile, AST was significantly lower in those with lobular inflammation of grade 1 than in those with grade 2-3. Hepcidin and resistin levels were significantly higher in patients with moderate to severe fibrosis than in those with mild fibrosis.

CONCLUSIONS

It seems that surrogate liver function tests and adipocytokine levels were correlated with the histologic findings of the liver.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是慢性肝炎的常见病因,可导致肝硬化和肝细胞癌。

目的

本研究旨在评估非酒精性脂肪性肝病(NAFLD)患者血清脂肪细胞因子与肝脏组织学检查结果之间的相关性。

患者与方法

本病例对照研究针对那些肝酶持续升高且超声检查有脂肪肝证据的患者。在排除其他导致肝功能检查异常的病因患者后,对剩余患者进行肝活检。根据Brunt评分系统,基于肝脏组织学诊断NAFLD。

结果

NAFLD患者的腰围、空腹血糖、胰岛素、甘油三酯、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平高于对照组。脂肪变性程度小于33%的患者的ALT、AST和γ-谷氨酰转移酶(GGT)水平低于脂肪变性程度较高的患者。小叶炎症为0 - 1级的患者的血清低密度脂蛋白(LDL)、胆固醇和铁调素水平显著高于炎症为2 - 3级的患者(Brunt评分)。同时,小叶炎症为1级的患者的AST显著低于2 - 3级的患者。中度至重度纤维化患者的铁调素和抵抗素水平显著高于轻度纤维化患者。

结论

似乎替代肝功能检查和脂肪细胞因子水平与肝脏组织学检查结果相关。

相似文献

1
The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者血清脂肪因子与肝细胞损伤的相关性
Hepat Mon. 2016 Apr 20;16(5):e37412. doi: 10.5812/hepatmon.37412. eCollection 2016 May.
2
Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease.血清脂肪因子可能预测非酒精性脂肪性肝病的肝脏组织学表现。
World J Gastroenterol. 2016 Jun 7;22(21):5096-103. doi: 10.3748/wjg.v22.i21.5096.
3
Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.非酒精性脂肪性肝病肥胖患儿血清脂联素、瘦素和抵抗素浓度。
Adv Med Sci. 2009;54(2):177-82. doi: 10.2478/v10039-009-0047-y.
4
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
5
Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.血清脯氨酰肽酶活性对预测非酒精性脂肪性肝病肝脏组织学病变的诊断价值:区分脂肪性肝炎与单纯性脂肪肝的替代标志物。
Dig Dis Sci. 2009 Aug;54(8):1764-71. doi: 10.1007/s10620-008-0535-0. Epub 2008 Nov 7.
6
Cholesteryl Ester Transfer Protein Variant (RS1800777) with Liver Histology in Non-Alcoholic Fatty Liver Disease Patients.载脂蛋白酯酶基因变异(RS1800777)与非酒精性脂肪性肝病患者的肝脏组织学。
Ann Nutr Metab. 2018;73(4):265-270. doi: 10.1159/000493552. Epub 2018 Oct 5.
7
[Clinical and histological features of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的临床和组织学特征
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6.
8
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统:一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
9
Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study).一组埃及非酒精性脂肪性肝病儿童的维生素D状况评估(多中心研究)。
Nutr Metab (Lond). 2016 Aug 19;13:53. doi: 10.1186/s12986-016-0112-z. eCollection 2016.
10
Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis.不同类型非酒精性肝病患者的血清脂联素水平。与脂肪变性、坏死性炎症和纤维化的相关性。
Acta Gastroenterol Belg. 2008 Oct-Dec;71(4):355-60.

引用本文的文献

1
The serum hepcidin and the hepcidin/ferritin ratio in NAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病中的血清铁调素及铁调素/铁蛋白比值:一项系统评价与荟萃分析
BMC Gastroenterol. 2025 Feb 6;25(1):62. doi: 10.1186/s12876-025-03620-9.
2
The Effect of a Multidisciplinary Lifestyle Intervention Program on Apelin-12, Vaspin and Resistin Concentrations in Children and Adolescents with Overweight and Obesity.多学科生活方式干预方案对超重和肥胖儿童和青少年的 Apelin-12、Vaspin 和抵抗素浓度的影响。
Nutrients. 2024 Oct 26;16(21):3646. doi: 10.3390/nu16213646.
3
Relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis B.慢性乙型肝炎患者血清脂联素和抵抗素水平与肝纤维化严重程度的关系
J Med Biochem. 2022 Apr 8;41(2):176-183. doi: 10.5937/jomb0-33793.
4
Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease.喜来芝在调节非酒精性脂肪肝大鼠抵抗素、脂联素和细胞因子中的保护作用。
Chin J Integr Med. 2022 Jun;28(6):531-537. doi: 10.1007/s11655-022-3307-3. Epub 2022 Mar 8.
5
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.非酒精性脂肪性肝病成年患者的血清抵抗素水平:一项系统评价和荟萃分析
J Clin Transl Hepatol. 2021 Aug 28;9(4):484-493. doi: 10.14218/JCTH.2021.00018. Epub 2021 May 17.
6
Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis.非酒精性脂肪性肝病和肝纤维化患者的血清内脂素水平:系统评价与Meta分析
J Clin Med. 2021 Jul 7;10(14):3029. doi: 10.3390/jcm10143029.
7
Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients.肝脏脂肪含量可能是评估非酒精性脂肪性肝炎患者心血管疾病风险的合适指标。
Med J Islam Repub Iran. 2020 Oct 12;34:135. doi: 10.34171/mjiri.34.135. eCollection 2020.
8
The Correlation between Serum Zinc Level and Liver Histology in Non-Alcoholic Steatohepatitis.非酒精性脂肪性肝炎患者血清锌水平与肝脏组织学的相关性
Iran J Pathol. 2019 Winter;14(1):17-25. doi: 10.30699/IJP.14.1.17. Epub 2018 Dec 27.
9
Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome.内脂素水平与代谢综合征中非酒精性脂肪肝的相关性
Med J Islam Repub Iran. 2017 May 28;31:28. doi: 10.18869/mjiri.31.28. eCollection 2017.
10
Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).普通狨猴(Callithrix jacchus)感染丙型肝炎病毒时的代谢失调
PLoS One. 2017 Jan 13;12(1):e0170240. doi: 10.1371/journal.pone.0170240. eCollection 2017.

本文引用的文献

1
The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝脏抵抗素过表达与炎症之间的关系。
BMC Gastroenterol. 2014 Feb 23;14:39. doi: 10.1186/1471-230X-14-39.
2
Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.血浆内脂素与非酒精性脂肪性肝病的肝及全身炎症的相关性。
Ann Hepatol. 2013 Jul-Aug;12(4):548-55.
3
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.脂联素:非酒精性脂肪性肝病中关键的脂肪细胞因子。
Clin Exp Med. 2014 May;14(2):121-31. doi: 10.1007/s10238-012-0227-0. Epub 2013 Jan 5.
4
Hepatocellular carcinoma in pakistan: where do we stand?巴基斯坦的肝细胞癌:我们目前的状况如何?
Hepat Mon. 2012 Oct;12(10 HCC):e6023. doi: 10.5812/hepatmon.6023. Epub 2012 Oct 10.
5
Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.非酒精性脂肪性肝病相关肝细胞癌的临床特征。
Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):18-27. doi: 10.1016/s1499-3872(11)60120-3.
6
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.铁在脂肪肝和代谢综合征中的作用:一个有前途的治疗靶点。
J Hepatol. 2011 Oct;55(4):920-32. doi: 10.1016/j.jhep.2011.05.008. Epub 2011 Jun 28.
7
Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者肝组织活检证实的血清铁调素水平。
Metab Syndr Relat Disord. 2011 Aug;9(4):287-90. doi: 10.1089/met.2010.0121. Epub 2011 Mar 21.
8
Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.接受减肥手术的非酒精性脂肪性肝病肥胖患者肝脏内内脏脂肪素的表达
Pol J Pathol. 2010;61(3):147-53.
9
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病患者血清脂联素水平:系统评价和荟萃分析。
Metabolism. 2011 Mar;60(3):313-26. doi: 10.1016/j.metabol.2010.09.003. Epub 2010 Oct 30.
10
Visceral adipose tissue visfatin in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的内脏脂肪组织内脏素。
Ann Hepatol. 2010 Jul-Sep;9(3):266-70.